Ana Serrato is a seasoned pharmaceutical executive with extensive expertise in innovative therapies, orphan drugs, and, more recently, Cannabinoid-Based Medicines (CBMs). With over 20 years of experience in the pharmaceutical and biotechnology sectors, she has held various leadership roles at both national and regional levels in major pharmaceutical companies and biotech startups. Originally from Colombia, Ana relocated to Germany in 2019 to take on the role of Global Pharma Head at Clever Leaves.

She later joined Avextra Pharma, where she currently leads the Clinical Development Team, driving innovative research and development in CBMs. A passionate advocate for CBM research and scientific data-driven initiatives, Ana is dedicated to advancing patient-centric policies. She works tirelessly to promote accessible and compassionate medical solutions across Europe. Since 2024, she was appointed as Chairwoman for EUMCA ( European Medical Cannabis Association). Ana holds a degree in Microbiology from the Universidad de los Andes in Bogotá, Colombia, and a Master’s in Business Administration from Universidad Carlos III in Madrid, Spain.